Efficacy and safety of Niaspan [niacin] in South Asian stroke survivors: NIASTAR trial (Niaspan: Indo-Asian Stroke Patient Atherosclerotic Regression trial)

Trial Profile

Efficacy and safety of Niaspan [niacin] in South Asian stroke survivors: NIASTAR trial (Niaspan: Indo-Asian Stroke Patient Atherosclerotic Regression trial)

Active, no longer recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 22 Nov 2006

At a glance

  • Drugs Niacin; Simvastatin
  • Indications Atherosclerosis
  • Focus Therapeutic Use
  • Acronyms NIASTAR
  • Most Recent Events

    • 22 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top